Koninklijke Philips (PHG) Research & Development (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Research & Development came in at -$461.3 million in Q1 2026, up 4.04% year-on-year from -$443.3 million in Q1 2025, and up 76.69% quarter-over-quarter from -$2.0 billion in Q4 2025.
Koninklijke Philips (PHG) Research & Development (2009 - 2026) Analysis & Trends
Koninklijke Philips' Research & Development history runs 18 years deep, the most recent figure standing at -$461.3 million for Q1 2026.
- On a quarterly basis, Research & Development rose 4.04% year-over-year to -$461.3 million in Q1 2026; TTM through Mar 2026 was -$4.4 billion, a 33.65% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 6.0% from the prior year.
- Research & Development improved to -$461.3 million in Q1 2026 per PHG's latest filing, from -$2.0 billion in the prior quarter.
- Across five years, Research & Development topped out at -$455.0 million in Q2 2025 and bottomed at -$2.0 billion in Q4 2023.
- The 5-year median for Research & Development is -$555.6 million (2022), against an average of -$916.1 million.
- Across the five-year window, Research & Development tumbled 297.84% in 2023 and surged 69.69% in 2024, its largest moves.
- Year by year, Research & Development stood at -$511.1 million in 2022, then tumbled by 297.84% to -$2.0 billion in 2023, then grew by 8.2% to -$1.9 billion in 2024, then slipped by 6.0% to -$2.0 billion in 2025, then surged by 76.69% to -$461.3 million in 2026.
- Per Business Quant, the three latest PHG Research & Development figures stand at -$461.3 million (Q1 2026), -$2.0 billion (Q4 2025), and -$1.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 28.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -461.27 Mn |
| Dec 31, 2025 | -1.98 Bn |
| Sep 30, 2025 | -1.49 Bn |
| Jun 30, 2025 | -455.05 Mn |
| Mar 31, 2025 | -480.71 Mn |
| Dec 31, 2024 | -1.87 Bn |
| Sep 30, 2024 | -475.53 Mn |
| Jun 30, 2024 | -456.60 Mn |
| Mar 31, 2024 | -455.19 Mn |
| Dec 31, 2023 | -2.03 Bn |
| Sep 30, 2023 | -1.57 Bn |
| Jun 30, 2023 | -1.08 Bn |
| Mar 31, 2023 | -566.72 Mn |
| Dec 31, 2022 | -511.14 Mn |
| Sep 30, 2022 | -617.06 Mn |
| Jun 30, 2022 | -518.59 Mn |
| Mar 31, 2022 | -555.56 Mn |
| Dec 31, 2021 | -543.39 Mn |
| Sep 30, 2021 | -515.35 Mn |
| Jun 30, 2021 | -1.08 Bn |